Amir A. Jazaeri

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0003-4335-4151

发表论文 480 篇 · 总被引 9124 次 · h-index 44

代表论文

Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study (2026 · International Journal of Gynecological Cancer · 被引 1)
Data from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S7 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S2 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S5 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S8 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)